Invention Grant
- Patent Title: Compositions and methods for treating ceacam positive cancers
-
Application No.: US17517559Application Date: 2021-11-02
-
Publication No.: US11433100B2Publication Date: 2022-09-06
- Inventor: Xueyin Wang , Carl Alexander Kamb , Han Xu , Mark L. Sandberg , Dora Toledo Warshaviak
- Applicant: A2 Biotherapeutics, Inc.
- Applicant Address: US CA Agoura Hills
- Assignee: A2 Biotherapeutics, Inc.
- Current Assignee: A2 Biotherapeutics, Inc.
- Current Assignee Address: US CA Agoura Hills
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent James R. Whittle; Anna Mirón
- Main IPC: A61K35/17
- IPC: A61K35/17 ; C07K14/705 ; A61P35/00 ; C07K14/725
Abstract:
The disclosure provides immune cells comprising a first activator receptor specific to CEA, and a second inhibitory receptor, and methods of making and using same for the treatment of cancer.
Public/Granted literature
- US20220054551A1 COMPOSITIONS AND METHODS FOR TREATING CEACAM POSITIVE CANCERS Public/Granted day:2022-02-24
Information query
IPC分类:
